Truvian Health announced it has raised $74m in funding for its automated benchtop blood testing analyzer, which aims to provide lab-accurate results for a comprehensive suite of routine blood tests in a single run.
The funding round was led by Wittington Ventures and Great Point Ventures with support from existing investors including DNS Capital,...







